ANDA 78454, held by Apotex Inc. Moexipril Hydrochloride.
As of Nov 16, 2026, ANDA 78454 (Moexipril Hydrochloride), held by Apotex Inc, was first approved by FDA on Jun 2, 2008, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 2, 2008 | Original application | Approved | None posted |
| Moexipril Hydrochloride7.5MG · tablet;oral | Moexipril Hydrochloride | Discontinued |
| Moexipril Hydrochloride15MG · tablet;oral | Moexipril Hydrochloride | Discontinued |
| Mar 2, 2015 | Supplement 2Labeling · Standard review | Approved | None posted |
| Sep 17, 2010 | Supplement 1Labeling | Approved | None posted |
| Jun 2, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters